. Overview of search strategy. -"Body composition"
MeSH-terms:
-"Tomography, X-Ray
Computed"
-Radiography
Emtree-terms:
-Stomach (exp)
-'Malignant neoplasm'
(exp)
-'Muscular atrophy'
-'Skeletal muscle' (exp)
-'Body composition'
-'Computer assisted tomography'
-'Digital imaging' (exp) Inferior reporting of patient cohort and in-and exclusion criteria. Inferior description of baseline study sample for important patient characteristics.
Study attrition
Adequate reporting of response rate, reasons for loss to follow up, and attempts to collect data from patients who dropped out of study.
Moderate reporting of response rate, reasons for loss to follow up, and attempts to collect data from patients who dropped out of study.
Inferior reporting of response rate, reasons for loss to follow up, and attempts to collect data from patients who dropped out of study.
Prognostic factor measurement
Adequate reporting of the method of muscle mass assessment. Blinded and experienced investigator. Cutoff value for low muscle mass was based on large patient cohorts and not data-dependent.
Moderate reporting of the method of muscle mass assessment. Blinded and experienced investigator. A data-dependent cutoff value was used for the definition of low muscle mass.
Inferior reporting of the method of muscle mass assessment. Not-blinded or inexperienced investigator. A data-dependent cutoff value was used for the definition of low muscle mass.
Outcome measurement
Adequate reporting of definition of outcomes, duration of follow-up, and method of outcome measurement.
Moderate reporting of definition of outcomes, duration of followup, and method of outcome measurement.
Inferior reporting of definition of outcomes, duration of followup, and method of outcome measurement.
Study confounding
Adequate accounting for possible confounders: BMI, gender, smoking/alcohol, TNM stage, performance score, histological type, therapy (surgery, chemotherapy), comorbidity, tumor location, regression grade in case of chemotherapy, nutritional status.
Moderate accounting for possible confounders: BMI, gender, smoking/alcohol, TNM stage, performance score, histological type, therapy (surgery, chemotherapy), comorbidity, tumor location, regression grade in case of chemotherapy, nutritional status.
Inferior accounting for possible confounders: BMI, gender, smoking/alcohol, TNM stage, performance score, histological type, therapy (surgery, chemotherapy), comorbidity, tumor location, regression grade in case of chemotherapy, nutritional status.
Statistical analysis and reporting
Meta-analysis with univariable analysis only.
Meta-analysis with multivariable analysis with covariables included that were significant in the univariable analysis (p < 0.05).
Meta-analysis with multivariable analysis with covariables included that were significant in the univariable analysis (p < 0.1). Figure S1 . Overview of the risk of bias score of the included studies following QUIPS. Figure S7. Sensitivity analysis: forest plots of univariable and multivariable odds ratios for severe postoperative complications for gastric cancer patients with low muscle mass versus normal muscle mass. Figure S8 . Sensitivity analysis: forest plots of univariable and multivariable odds ratios for overall survival for gastric cancer patients with low muscle mass versus normal muscle mass.
